We are live on ! Find out more
CPIG

Chicago Partners Investment Group Portfolio holdings

AUM $5B
1-Year Est. Return 26.84%
This Fund
S&P 500
This Quarter Est. Return
+10.29%
1 Year Est. Return
+26.84%
3 Year Est. Return
+75.76%
5 Year Est. Return
+80.52%
10 Year Est. Return
+204.97%
AUM
$2.16B
AUM Growth
+$308M
Cap. Flow
+$58.8M
Cap. Flow %
2.72%
Top 10 Hldgs %
24.76%
Holding
722
New
65
Increased
324
Reduced
283
Closed
21

Sector Composition

Rank Sector Weight
1 Energy 8.67%
2 Financials 8.43%
3 Technology 7.63%
4 Healthcare 2.28%
5 Consumer Discretionary 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAL icon
676
American Airlines Group
AAL
$9.93B
$147K 0.01%
10,586
+39
+0.4% +$490
PGX icon
677
Invesco Preferred ETF
PGX
$3.76B
$135K 0.01%
11,607
-45,912
-80% -$501K
MFM
678
Aberdeen Municipal Income Fund
MFM
$222M
$130K 0.01%
25,237
+5,216
+26% +$25.2K
SLCA
679
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$129K 0.01%
12,127
HPP
680
Hudson Pacific Properties
HPP
$740M
$125K 0.01%
+2,071
New +$91.3K
SCYX icon
681
SCYNEXIS
SCYX
$51.2M
$96K ﹤0.01%
6,542
-123
-2% -$1.8K
GLO
682
Clough Global Opportunities Fund
GLO
$257M
$74.2K ﹤0.01%
15,750
+2,889
+22% +$13K
GERN icon
683
Geron
GERN
$949M
$71K ﹤0.01%
34,118
+4,252
+14% +$8.27K
DRTSW icon
684
Alpha Tau Medical Warrant
DRTSW
$81M
$60.6K ﹤0.01%
205,824
+2,500
+1% +$605
ABOS icon
685
Acumen Pharmaceuticals
ABOS
$176M
$59.2K ﹤0.01%
18,315
+4,736
+35% +$14.1K
WVE icon
686
Wave Life Sciences
WVE
$1.2B
$49.7K ﹤0.01%
11,303
+167
+1% +$893
VOR icon
687
Vor Biopharma
VOR
$1.27B
$40.5K ﹤0.01%
866
-34
-4% -$1.4K
REAL icon
688
The RealReal
REAL
$1.45B
$40.5K ﹤0.01%
+21,069
New +$41K
CLYM
689
Climb Bio
CLYM
$778M
$36.2K ﹤0.01%
12,160
-646
-5% -$1.68K
SSKN
690
DELISTED
Strata Skin Sciences
SSKN
$33.4K ﹤0.01%
6,422
+3,970
+162% +$20.6K
WTI icon
691
W&T Offshore
WTI
$577M
$32.6K ﹤0.01%
10,621
-1,841
-15% -$6.79K
ESPR
692
DELISTED
Esperion Therapeutics
ESPR
$30.6K ﹤0.01%
15,066
-14,433
-49% -$18.7K
CTSO icon
693
Cytosorbents Corp
CTSO
$22.7M
$27.4K ﹤0.01%
30,836
-5,522
-15% -$8.2K
ACRS icon
694
Aclaris Therapeutics
ACRS
$868M
$26.4K ﹤0.01%
+20,988
New +$64K
LUMN icon
695
Lumen
LUMN
$6.85B
$21.9K ﹤0.01%
16,198
+29
+0.2% +$41
BFLY icon
696
Butterfly Network
BFLY
$2.58B
$17.5K ﹤0.01%
17,651
+6,679
+61% +$6.61K
RGF
697
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$17.2K ﹤0.01%
+1,186
New +$29.4K
QUBT icon
698
Quantum Computing Inc
QUBT
$2.01B
$14.6K ﹤0.01%
15,664
BNED icon
699
Barnes & Noble Education
BNED
$444M
$13K ﹤0.01%
142
-45
-24% -$5K
TCRT icon
700
Alaunos Therapeutics
TCRT
$4.84M
$2.6K ﹤0.01%
94

Similar funds

Chicago Partners Investment Group's Q4 2023 Portfolio in Review

As of Q4 2023, Chicago Partners Investment Group held 722 positions worth $2.16B, up 17% from $1.85B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Chicago Partners Investment Group's Q4 2023 filing shows 65 new, 324 increased, 283 reduced and 21 closed positions. Its largest new stake was Nuveen Preferred & Income Opportunities Fund: 269,535 shares worth $1.91M. The largest sale was Brookfield, an estimated $1.58M.

By sector, the portfolio is most concentrated in Energy at 8.7% of assets, down from 9.8% a quarter earlier, followed by Financials and Technology.

  • Chicago Partners Investment Group's largest Q4 2023 buy was Nuveen Preferred & Income Opportunities Fund: 269,535 shares worth $1.91M.
  • Chicago Partners Investment Group added most to Vanguard S&P 500 ETF in Q4 2023, an estimated $5.73M increase.
  • Chicago Partners Investment Group's biggest Q4 2023 reduction was Brookfield, cutting an estimated $1.58M.
  • Chicago Partners Investment Group fully exited iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036 in Q4 2023, selling an estimated $1.29M.
  • Chicago Partners Investment Group's ten largest holdings make up 25% of its $2.16B portfolio in Q4 2023.
  • Chicago Partners Investment Group opened 65 new positions and closed 21 in Q4 2023.
  • Chicago Partners Investment Group's portfolio value rose 17% quarter-over-quarter to $2.16B.

Based on Chicago Partners Investment Group's 13F filing for Q4 2023, filed 23 Feb 2024.